Form 8-K COGENT COMMUNICATIONS For: Aug 06
false
0001158324
DC
0001158324
2026-08-06
2026-08-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT Pursuant to Section 13 or 15(d) of the... (continue reading...)
Form 10-Q Sionna Therapeutics, For: Jun 30
0002036042falseQ22026--12-31Reportable... (continue reading...)
Form FWP Primo Brands Corp Filed by: Primo Brands Corp
Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement No. 333-284501
Related to Prospectus dated December 4, 2025
Press Release
Primo Brands Corporation Announces Secondary Offering of
20,000,000 Shares of Class A Common Stock by an Affiliate of One Rock Capital Partners
TAMPA, Fla. and STAMFORD, Conn. – August 6, 2026 – Primo Brands Corporation (NYSE: PRMB) (“Primo Brands” or the “Company”) today... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K D-Wave Quantum Inc. For: Aug 06
-
Form 8-K Sotera Health Co For: Aug 06
-
Form 425 DANA Inc Filed by: DANA Inc
-
Form 424B3 Primo Brands Corp
-
Form SCHEDULE 13G/A Intuitive Machines, Inc. Filed by: Voya Financial, Inc.
-
Form N-PX WFM ASIA (BVI) Ltd For: Jun 30
-
Form N-PX WFM ASIA (HK) Ltd For: Jun 30
-
Form SCHEDULE 13G/A Arhaus, Inc. Filed by: Voya Financial, Inc.
-
Form 10-Q PRECISION BIOSCIENCES For: Jun 30
-
Form 8-K Driven Brands Holdings For: Aug 06
-
Form 8-K FrontView REIT, Inc. For: Aug 06
-
Form 10-Q REGENXBIO Inc. For: Jun 30
-
Form 8-K PRECISION BIOSCIENCES For: Aug 06
-
Form SCHEDULE 13G/A TANDEM DIABETES CARE Filed by: Voya Financial, Inc.
-
Form 8-K HARROW, INC. For: Aug 03
-
Form 8-K FISERV INC For: Aug 06
-
Form 8-K Immunovant, Inc. For: Aug 06
-
Form 8-K Aclaris Therapeutics, For: Aug 06
-
Form 8-K Versant Media Group, For: Aug 06
-
Form 8-K Roivant Sciences Ltd. For: Aug 06
-
Form 13F-HR HS Management Partners, For: Jun 30
-
Form 8-K Xeris Biopharma Holdings For: Aug 06
-
Form 8-K Sionna Therapeutics, For: Aug 06
-
Form 8-K IRONWOOD PHARMACEUTICALS For: Aug 06
-
Form 8-K Tarsus Pharmaceuticals, For: Aug 05
-
Form 10-Q Cullinan Therapeutics, For: Jun 30
-
Form 8-K CareCloud, Inc. For: Aug 06
-
Form 8-K Bausch & Lomb Corp For: Aug 05
-
Form 8-K Scholar Rock Holding For: Aug 06
-
Form 8-K REGENXBIO Inc. For: Aug 06
-
Form 10-Q TIC Solutions, Inc. For: Jun 30
-
Form 13F-NT Fullerton Fund Investmen For: Jun 30
-
Form 10-Q Monte Rosa Therapeutics, For: Jun 30
-
Form 10-Q Commerce.com, Inc. For: Jun 30
-
Form 10-Q Vistance Networks, Inc. For: Jun 30
-
Form 13F-HR AMF Tjanstepension AB For: Jun 30
-
Form 10-K OPEN TEXT CORP For: Jun 30
-
Form 10-Q Korro Bio, Inc. For: Jun 30
-
Form 8-K Tarsus Pharmaceuticals, For: Jul 31
-
Form 13F-NT Evans Investments Pte. For: Jun 30
-
Form 8-K SharonAI Holdings Inc. For: Aug 06
-
Form 8-K TELEFLEX INC For: Aug 06
-
Form 6-K ATS Corp /ATS For: Jun 28
-
Form 10-Q Core Natural Resources, For: Jun 30
-
Form 8-K Datadog, Inc. For: Aug 06
-
Form 8-K Vistance Networks, Inc. For: Aug 06
-
Form 13F-NT Esta Investments Pte. For: Jun 30
-
Form 6-K AXIA Energia S.A. For: Jun 30
-
Form 8-K OPEN TEXT CORP For: Aug 06
-
Form 8-K Commerce.com, Inc. For: Aug 06

